EMYRIA LIMITED

3.57%

2.9¢

Market Cap $17.73M

Healthcare Biotechnology

Emyria Limited is an Australia-based early-stage drug development company. The Company is... Emyria Limited is an Australia-based early-stage drug development company. The Company is focused on delivering and developing treatments for mental health and select neurological conditions, guided by real-world data collected with patients across its wholly owned clinical service subsidiaries. Its pipeline comprises MDMA analogue drug development and commercialization of novel serotonin-releasing agents. Its Emyria Healthcare provides evidence-based treatment for patients not finding relief from conventional care, while also helping evaluate emerging new therapies like assisted therapy for post-traumatic stress disorder (PTSD) and assisted therapy for treatment-resistant depression. Its Emyria Data is a robust and ethically sourced real-world data gathered with patients and used to improve its therapy and drug development programs. Its Emyria’s Pipeline includes new psychedelic-assisted therapies and drug treatments for mental health and select neurological diseases.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

Latest Threads

Tag

Subject

EMD

Ann: Ceasing to be a substantial holder

11/07/25

3.0K

11/07/25

Last post M Sugar

3.0K

EMD

general talk

6 7 8

29/06/25

439

170K

29/06/25

Last post FiSaver

439

170K

EMD Medicine

NZ singer Lorde discusses using MDMA therapy to work through stage fright, on US talkshow Late Show with Stephen Colbert

27/06/25

237

27/06/25

Last post DustyOne

237

EMD

Ann: Section 708A(5)(e) Notice

26/06/25

225

26/06/25

Last post

ASX News

225

EMD

Ann: Application for quotation of securities - EMD

26/06/25

199

26/06/25

Last post

ASX News

199

EMD

Ann: EMD Presents Medibank Deal to US Psychedelic Conference

21/06/25

1.2K

21/06/25

Last post FiSaver

1.2K

EMD

Ann: Medibank to Fund Emyria's PTSD Program at Perth Clinic

19/06/25

8.7K

19/06/25

Last post Pridar

8.7K

EMD

Ann: Proposed issue of securities - EMD

18/06/25

243

18/06/25

Last post

ASX News

243

See All Discussions

Timeline

Ceasing to be a substantial holder
30 Jun 08:22	Share

Section 708A(5)(e) Notice
26 Jun 11:07	Share

Application for quotation of securities - EMD
26 Jun 11:04	Share

EMD Presents Medibank Deal to US Psychedelic Conference
20 Jun 09:41	Share

Proposed issue of securities - EMD
18 Jun 09:44	Share

Proposed issue of securities - EMD
18 Jun 09:44	Share

Trading Halt
16 Jun 09:48	Share

PTSD Gains Sustained at 6m Follow-Up, MOU Signed with ANU
28 May 08:38	Share

Ceasing to be a substantial holder
19 May 19:26	Share

Notification of cessation of securities - EMD
14 May 08:17	Share

March 2025 Quarterly Activities Report and Appendix 4C
29 Apr 09:33	Share

Emyria Opens New Empax Centre to Meet Demand and Payer Needs
14 Apr 08:22	Share

Change of Director's Interest Notice - M. Winlo
09 Apr 09:24	Share

Section 708A(5)(e) Notice
31 Mar 17:51	Share

Becoming a substantial holder
31 Mar 17:50	Share

Change of Director's Interest Notice x 2
31 Mar 17:40	Share

Notification regarding unquoted securities - EMD
31 Mar 17:31	Share

Application for quotation of securities - EMD
31 Mar 17:16	Share

Results of Meeting
19 Mar 19:25	Share

Section 708A(5)(e) Notice
05 Mar 10:06	Share

Notification regarding unquoted securities - EMD
05 Mar 10:03	Share

Application for quotation of securities - EMD
05 Mar 09:57	Share

Appendix 4D and Half Year End Financial Report
27 Feb 09:21	Share

Letter to Shareholders - Notice of General Meeting
14 Feb 14:13	Share

Notice of General Meeting/Proxy Form
14 Feb 14:13	Share

Euroz Hartleys 2025 Healthcare Forum Presentation
04 Feb 09:31	Share

Emyria Reports Promising 3-Month PTSD Treatment Results
04 Feb 09:25	Share

December 2024 Quarterly Activities Report and Appendix 4C
31 Jan 12:15	Share

Leadership Updates
22 Jan 09:20	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.9¢		Change 0.001(3.57%)		Mkt cap ! $17.73M

Open	High	Low	Value	Volume
2.7¢	2.9¢	2.7¢	$64.38K	2.272M

Buyers (Bids)

No.	Vol.	Price($)
1	362052	2.8¢

Sellers (Offers)

Price($)	Vol.	No.
2.9¢	229901	1

View Market Depth

No.	Vol.	Price($)
1	362052	0.028
4	200506	0.027
4	262711	0.026
3	540000	0.025
6	979393	0.024

Price($)	Vol.	No.
0.029	229901	1
0.030	907104	4
0.031	94812	1
0.032	92000	1
0.034	116570	2

Last trade - 16.10pm 11/07/2025 (20 minute delay)

EMD (ASX) Chart

EMYRIA LIMITED

Latest Threads

Timeline

Featured News

Latest Videos

Emyria (ASX:EMD) recruits first patient in MDMA-assisted therapy trial for PTSD

10 Jul 2023 12:47 (AEST)

Emyria (ASX:EMD) pockets more than $2m R&D tax refund

12 Jan 2023 10:34 (AEDT)

Latest Articles

Emyria opens second Empax centre in Perth to meet mental health demand

Emyria Ltd has launched a second Empax clinic in Western Australia, aiming to support patients with depression and PTSD

Emyria to plug $2.5M into depression treatment program at Empax Centre

Emyria Ltd has rolled out a Placement to raise more than $2M to expand mental health treatments at its Leederville centre

Emyria, UWA seek commercialisation of compounds to treat PTSD and Parkinson's

Emyria and the University of Western Australia have formed a partnership to secure global rights to a library of patented compounds.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News